Esther Rajavelu - Insider Trading & Ownership

Entity
Individual
Location
26 Landsdowne Street, Cambridge, MA
Summary
The estimated net worth of Esther Rajavelu is at least $609K dollars as of February 5, 2024. Esther Rajavelu is the Chief Financial Officer and Chief Business Officer of Spero Therapeutics, Inc. and owns shares of Spero Therapeutics, Inc. (SPRO) stock worth about $609K.
All Insider Reports
All Insider Reports

Ownership of Esther Rajavelu

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SPRO Spero Therapeutics, Inc. Chief Financial Officer and Chief Business Officer $609K Feb 1, 2024
FULC Fulcrum Therapeutics, Inc. Chief Financial Officer Feb 9, 2023

Insider Transactions Reported by Esther Rajavelu:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.